Characterizing Plasma Biomarkers of Alzheimer’s in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
Proteomic Profiles of Neurodegeneration among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study
Analysis of a precision medicine approach to treating Parkinson’s disease: Analysis of the DATATOP study
A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research.
A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
Blood-based biomarkers for Down syndrome and Alzheimer’s disease: A systematic review
Potential two-step proteomic signature for Parkinson’s disease: Pilot analysis in the Harvard Biomarkers Study
A proteomic signature for dementia with Lewy bodies
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease
Blood biomarkers for Use in Azheimer’s Disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
A blood screening test for Alzheimer’s disease
Comparing biological markers of Alzheimer’s disease across blood fraction and platforms: Comparing apples to oranges
Validation of a serum screen for Alzheimer’s disease across assay platforms, species, and tissues
Developing novel blood-based biomarkers for Alzheimer’s disease
A blood-based screening tool for Alzheimer’s disease that spans serum and plasma: Findings from TARC and ADNI
A blood-based algorithm for the detection of Alzheimer’s disease
